Products Bazedoxifene is commercially available in the form of film-coated tablets (Conbriza). It has been approved in many countries since 2010. In 2015, a fixed combination with conjugated estrogens was registered (Duavive). This article refers to monotherapy. Structure and properties Bazedoxifene (C30H34N2O3, Mr = 470.60 g/mol) is a nonsteroidal selective estrogen receptor modulator developed from … Bazedoxifene
Products Raloxifene is commercially available in the form of film-coated tablets (Evista). It has been approved in many countries since 2000. Structure and properties Raloxifene (C28H27NO4S, Mr = 473.6 g/mol) is present in the drug as raloxifene hydrochloride, a benzothiophene and white to yellowish powder that is sparingly soluble in water. Effects Raloxifene (ATC G03XC01) … Raloxifene
Products Ospemifene is commercially available in tablet form (Osphena). It was approved in the United States in February 2013. It is not yet registered in many countries. Structure and properties Ospemifene (C24H23ClO2, Mr = 378.9 g/mol) exists as a white crystalline powder that is insoluble in water. It is a triphenylethylene derivative and has a … Ospemifene
